谷歌浏览器插件
订阅小程序
在清言上使用

S144 CP101 Engraftment Drives Efficacy: Results from a Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for Prevention of Recurrent C. Difficile Infection

The American Journal of Gastroenterology(2021)

引用 1|浏览4
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要